Topics:

Rheumatic Diseases

Rheumatic Diseases

Here: a primary care perspective on diagnosis of -- and care of patients with -- rheumatologic disorders.

Rheumatic Diseases

Are you letting meaningless details squander your mental currency in rheumatology practice? The author points out how to recapture energy stolen by mere paperwork that should be used on your real job: Patient care.

rheumatoid arthritis

One very targeted clue to treatment failure: An observational study from Israel identifies Sephardic Jews as more likely than Ashkenazim to form antibodies against the biologic drug infliximab.

rheumatoid arthritis

Slides summarize of a Twitter-based journal club, pondering a randomized study of tapering TNF inhibitors in rheumatoid arthritis. Many questions about the study design; more about tapering practices already in clinical use, which are addressed in Part 2.

gout

Expert rheumatologists examine patterns of treatment failure in gout, in light of six recent guidelines on the condition. This brief slide show based on their review summarizes basics about the guidelines and the clues to optimal treatment, linking to the review itself.

A new app-based registry focusing on rheumatoid and psoriatic arthritis and ankylosing spondylitis aims to use patient-generated data to resolve important unanswered clinical questions. Its rheumatologist sponsor urges you to encourage patients to join up.

Studies on banked cells from humans in different regions of the world reveal that many genes that control immune function behave differently in winter and summer. They are more pro-inflammatory in the winter.

Top reports chosen by Annals of Internal Medicine include several on biologics for rheumatoid arthritis and psoriatic arthritis, and mechanisms for lupus and scleroderma.

Pages

Subscribe to Rheumatic Diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.